HCM
SOPH icon

Hodges Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Hodges Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Sell
409,073
-26,763
-6% -$136K 0.16% 129
2026
Q1 		$2.16M Buy
+435,836
New +$2.12M 0.18% 119

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Hodges Capital Management's SOPH Position: Q2 2026 in Review

Hodges Capital Management reduced its SOPHiA GENETICS (SOPH) stake by 6.1% in Q2 2026, selling an estimated $136K and leaving 409,073 shares worth $2.36M. The position accounts for 0.16% of the portfolio, ranked #129.

Hodges Capital Management first reported a position in SOPH in Q1 2026 and has held it in 2 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Hodges Capital Management held 409,073 shares of SOPHiA GENETICS worth $2.36M as of Q2 2026.
  • Hodges Capital Management sold 26,763 SOPHiA GENETICS shares in Q2 2026, an estimated $136K.
  • SOPHiA GENETICS made up 0.16% of Hodges Capital Management's portfolio in Q2 2026, its #129 holding.
  • Hodges Capital Management first reported a position in SOPHiA GENETICS in Q1 2026 and has held it in 2 quarters since.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Hodges Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.